Seite - 61 - in Advances in Neuroimmunology

BrainSci. 2016,6, 41 26. Gerhard,A.;Trender-Gerhard, I.;Turkheimer,F.;Quinn,N.P.;Bhatia,K.P.;Brooks,D.J. Invivo imagingof microglialactivationwith[11C](R)-PK11195PETinprogressivesupranuclearpalsy.Mov.Disord. 2006,21, 89–93. [CrossRef] [PubMed] 27. Goldman,S.M.;Tanner,C.M.;Oakes,D.; Bhudhikanok,G.S.;Gupta,A.; Langston, J.W.Head injuryand Parkinson’sdiseaserisk in twins.Ann.Neurol. 2006,60, 65–72. [CrossRef] [PubMed] 28. Lawson,L.J.;Perry,V.H.;Dri,P.;Gordon,S.Heterogeneity in thedistributionandmorphologyofmicroglia in thenormaladultmousebrain.Neuroscience1990,39, 151–170. [CrossRef] 29. Sharma,N.;Nehru,B.Characterizationof the lipopolysaccharide inducedmodelofParkinson’sdisease: Roleofoxidativestressandneuroinflammation.Neurochem. Int. 2015,87, 92–105. [CrossRef] [PubMed] 30. Codolo,G.;Plotegher,N.;Pozzobon,T.;Brucale,M.;Tessari, I.;Bubacco,L.;deBernard,M.Triggeringof inflammasomebyaggregatedα-synuclein,an inflammatoryresponse insynucleinopathies.PLoSONE2013, 8, e55375. [CrossRef] [PubMed] 31. Reynolds,A.D.;Glanzer, J.G.;Kadiu, I.; Ricardo-Dukelow,M.;Chaudhuri,A.;Ciborowski, P.;Cerny,R.; Gelman,B.;Thomas,M.P.;Mosley,R.L.; etal.Nitratedalpha-synuclein-activatedmicroglialprofiling for Parkinson’sdisease. J.Neurochem. 2008,104, 1504–1525. [CrossRef] [PubMed] 32. Cao, S.; Theodore, S.; Standaert, D.G. Fcγ receptors are required for NF-κB signaling, microglial activationanddopaminergicneurodegeneration inanAAV-synucleinmousemodelofParkinson’sdisease. Mol. Neurodegener. 2010,5, 42. [CrossRef] [PubMed] 33. Cao, S.; Standaert, D.G.; Harms, A.S. The gamma chain subunit of Fc receptors is required for alpha-synuclein-inducedpro-inflammatorysignaling inmicroglia. J.Neuroinflamm. 2012,9, 259. [CrossRef] [PubMed] 34. Polinski,N.K.;Gombash,S.E.;Manfredsson,F.P.;Lipton, J.W.;Kemp,C.J.;Cole-Strauss,A.;Kanaan,N.M.; Steece-Collier,K.;Kuhn,N.C.;Wohlgenant,S.L.; etal. Recombinantadenoassociatedvirus2/5-mediated genetransfer is reducedintheagedratmidbrain.Neurobiol. Aging2015,36, 1110–1120. [CrossRef] [PubMed] 35. Nash,K.R.;Moran,P.;Finneran,D.J.;Hudson,C.;Robinson, J.;Morgan,D.;Bickford,P.C.Fractalkineover expression suppressesα-synuclein-mediatedneurodegeneration. Mol. Ther. 2015, 23, 17–23. [CrossRef] [PubMed] 36. Morganti, J.M.;Nash,K.R.;Grimmig,B.A.;Ranjit,S.;Small,B.;Bickford,P.C.;Gemma,C.Thesoluble isoform ofCX3CL1isnecessaryforneuroprotection inamousemodelofParkinson’sdisease. J.Neurosci. 2012,32, 14592–14601. [CrossRef] [PubMed] 37. Pabon, M.M.; Jernberg, J.N.; Morganti, J.; Contreras, J.; Hudson, C.E.; Klein, R.L.; Bickford, P.C. A spirulina-enhanced diet provides neuroprotection in an α-synuclein model of Parkinson’s disease. PLoSONE2012,7, e45256. [CrossRef] [PubMed] 38. Pabon,M.M.;Bachstetter,A.D.;Hudson,C.E.;Gemma,C.;Bickford,P.C.CX3CL1reducesneurotoxicityand microglialactivation inaratmodelofParkinson’sdisease. J.Neuroinflamm. 2011,8, 9. [CrossRef] [PubMed] 39. Rees,K.;Stowe,R.;Patel,S.; Ives,N.;Breen,K.;Clarke,C.E.;Ben-Shlomo,Y.Non-steroidalanti-inflammatory drugs as disease-modifying agents for Parkinson’s disease: Evidence from observational studies. Cochrane DatabaseSyst. Rev. 2011,11,CD008454. [PubMed] 40. Du, Y.; Ma, Z.; Lin, S.; Dodel, R.C.; Gao, F.; Bales, K.R.; Triarhou, L.C.; Chernet, E.; Perry, K.W.; Nelson,D.L.; et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in theMPTP modelofParkinson’sdisease.Proc.Natl. Acad. Sci.USA2001,98, 14669–14674. [CrossRef] [PubMed] 41. Lee,S.M.;Yune,T.Y.;Kim,S.J.;Kim,Y.C.;Oh,Y.J.;Markelonis,G.J.;Oh,T.H.Minocycline inhibitsapoptotic celldeathviaattenuationofTNF-alphaexpressionfollowing iNOS/NOinductionby lipopolysaccharide in neuron/gliaco-cultures. J.Neurochem. 2004,91, 568–578. [CrossRef] [PubMed] 42. Jones,B.A.;Beamer,M.;Ahmed,S.Fractalkine/CX3CL1:Apotentialnewtarget for inflammatorydiseases. Mol. Interv. 2010,10, 263–270. [CrossRef] [PubMed] 43. Cardona,A.E.; Pioro, E.P.; Sasse,M.E.; Kostenko,V.; Cardona, S.M.;Dijkstra, I.M.;Huang,D.; Kidd,G.; Dombrowski,S.;Dutta,R.; etal. Controlofmicroglialneurotoxicitybythefractalkinereceptor.Nat.Neurosci. 2006,9, 917–924. [CrossRef] [PubMed] 44. Thome,A.D.; Standaert,D.G.;Harms,A.S.Fractalkinesignalingregulates the inflammatoryresponse in anα-synucleinmodelofParkinsondisease.PLoSONE2015,10, e0140566. [CrossRef] [PubMed] 61